Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Optimaliseren van MRI-metingen bij MS-patiënten
sep 2025 | Multipele Sclerose